We are live on
!
Find out more
LIM
Loudon Investment Management Portfolio holdings
AUM
$186M
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.9%
1 Year Est. Return
+14.24%
3 Year Est. Return
+50.1%
5 Year Est. Return
+68.78%
10 Year Est. Return
+321.58%
AUM
$126M
AUM Growth
-$7.74M
(-5.8%)
Cap. Flow
+$363K
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
35.44%
Holding
90
New
5
Increased
22
Reduced
30
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$2.35M |
| 2 |
Target
TGT
|
+$1.9M |
| 3 |
Pentair
PNR
|
+$1.61M |
| 4 |
JPMorgan Chase
JPM
|
+$865K |
| 5 |
Blackrock
BLK
|
+$647K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.63M |
| 2 |
Truist Financial
TFC
|
+$781K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$743K |
| 4 |
Leggett & Platt
LEG
|
+$681K |
| 5 |
Merck
MRK
|
+$676K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.06% |
| 2 | Technology | 17.26% |
| 3 | Healthcare | 14.09% |
| 4 | Consumer Staples | 9.24% |
| 5 | Consumer Discretionary | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vertex Pharmaceuticals
VRTX
$134B
| $300K | 0.24% |
1,035
-1,165
| -53% | -$335K |
|
77
PPG Industries
PPG
$25.8B
| $291K | 0.23% |
+2,627
| New | +$325K |
|
78
ConocoPhillips
COP
$151B
| $288K | 0.23% |
2,815
| – | – |
|
79
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
| $279K | 0.22% |
6,976
+376
| +6% | +$16.7K |
|
80
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $273K | 0.22% |
3,715
| – | – |
|
81
Philip Morris
PM
$290B
| $265K | 0.21% |
3,191
| – | – |
|
82
Paychex
PAYX
$43.1B
| $264K | 0.21% |
2,350
| – | – |
|
|
83
Truist Financial
TFC
$63.9B
| $263K | 0.21% |
6,035
-16,236
| -73% | -$781K |
|
84
Colgate-Palmolive
CL
$73.6B
| $257K | 0.2% |
3,664
| – | – |
|
85
Ecolab
ECL
$79.8B
| $252K | 0.2% |
+1,748
| New | +$284K |
|
86
FedEx
FDX
$76.3B
| $224K | 0.18% |
1,506
+67
| +5% | +$14.1K |
|
87
US Bancorp
USB
$100B
| $219K | 0.17% |
5,435
| – | – |
|
|
CIXX
88
DELISTED
CI Financial Corp.
CIXX
| $177K | 0.14% |
18,500
| – | – |
|
89
Kimberly-Clark
KMB
$36.1B
| – | – |
-3,081
| Closed | -$416K |
|
90
McCormick & Company Voting
MKC.V
$14.2B
| – | – |
-5,155
| Closed | -$429K |
|
Similar funds
SSCM
PFG
SVBP
RCM
BGA
JHC
CPP
VFG
Loudon Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Loudon Investment Management held 90 positions worth $126M, down 5.8% from $133M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loudon Investment Management's Q3 2022 filing shows 5 new, 22 increased, 30 reduced and 2 closed positions. Its largest new stake was T. Rowe Price: 19,728 shares worth $2.07M. The largest sale was AbbVie, an estimated $1.63M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Loudon Investment Management's largest Q3 2022 buy was T. Rowe Price: 19,728 shares worth $2.07M.
- Loudon Investment Management added most to Target in Q3 2022, an estimated $1.9M increase.
- Loudon Investment Management's biggest Q3 2022 reduction was AbbVie, cutting an estimated $1.63M.
- Loudon Investment Management fully exited McCormick & Company Voting in Q3 2022, selling an estimated $429K.
- Loudon Investment Management's ten largest holdings make up 35% of its $126M portfolio in Q3 2022.
- Loudon Investment Management opened 5 new positions and closed 2 in Q3 2022.
- Loudon Investment Management's portfolio value fell 5.8% quarter-over-quarter to $126M.
Based on Loudon Investment Management's 13F filing for Q3 2022, filed 8 Nov 2022.